{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:13:03Z","timestamp":1787026383844,"version":"build-2736575974"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Whether elevated remnant cholesterol (RC) is associated with hypertension (HTN) and whether elevated RC interacts with diabetes on the subsequent risk of HTN have not been illustrated. Thus, this study is aimed to investigate the associations and interactions of RC, diabetes, and the management of cardiovascular risk factors with the risk of incident HTN in a Chinese population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>This cohort study included 42,994 individuals who participated in the routine health check-up from April 2016 to August 2020 and follow-ups from April 2017 to August 2021 at the Medical Examination Center of Beijing Chao-Yang Hospital. RC was divided into quintiles as follows: the &amp;lt; 20% group, the 20\u201339% group, the 40\u201359% group, the 60\u201379% group, and the \u2265 80% group. This study finally included 17,006 participants who were free from HTN at baseline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study had 1,861 (10.90%) HTN occurred, 205 (5.30%) in the first quintile of RC, 335 (8.98%) in the second quintile of RC, 388 (11.17%) in the third quintile of RC, 420 (13.42%) in the fourth quintile of RC, and 513 (17.91%) in the fifth quintile of RC. Compared with participants in the first quintile of RC, participants in the fifth quintile of RC showed a greater risk of HTN events among participants with diabetes [hazard ratio (HR), 4.95; 95% confidence interval (CI), 1.05\u201323.39; P = 0.0432) than among participants without diabetes (HR, 1.67; 95% CI, 1.26\u20132.22, P = 0.0004; P for interaction = 0.0420). Compared with participants without diabetes, participants with diabetes who have the ideal management of RC and other risk factors showed no excess risk of HTN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated RC is significantly predictive of HTN among the diabetic population. RC and diabetes interacted with each other on the subsequent risk of HTN, and the desired management of RC, glucose, and cardiovascular risk factors on HTN risk was quite favorable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2022.951635","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T02:08:45Z","timestamp":1661393325000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The association of remnant cholesterol (RC) and interaction between RC and diabetes on the subsequent risk of hypertension"],"prefix":"10.3389","volume":"13","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/cir.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: A report from the American heart association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamainternmed.2017.6015","article-title":"Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: A systematic review and meta-analysis","volume":"178","author":"Brunstr\u00f6m","year":"2018","journal-title":"JAMA Intern Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.12.1313","article-title":"Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study","volume":"164","author":"O'Meara","year":"2004","journal-title":"Arch Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.114.04262","article-title":"Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study","volume":"64","author":"Kario","year":"2014","journal-title":"Hypertension"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.20045","article-title":"Association of triglyceride-lowering LPL variants and LDL-C-Lowering LDLR variants with risk of coronary heart disease","volume":"321","author":"Ference","year":"2019","journal-title":"Jama"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"Jama"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. evidence from genetic, epidemiologic, and clinical studies. a consensus statement from the European atherosclerosis society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-c and cardiovascular risk reduction among different therapeutic interventions: A systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"Jama"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2011.70","article-title":"Triglycerides and triglycerides to high-density lipoprotein cholesterol ratio are strong predictors of incident hypertension in middle Eastern women","volume":"26","author":"Tohidi","year":"2012","journal-title":"J Hum Hypertens"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-1726","article-title":"Triglyceride to HDL-c ratio and increased arterial stiffness in children, adolescents, and young adults","volume":"131","author":"Urbina","year":"2013","journal-title":"Pediatrics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.03.014","article-title":"Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries","volume":"285","author":"De Backer","year":"2019","journal-title":"Atherosclerosis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.111.088591","article-title":"Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the treating to new targets (TNT) study","volume":"125","author":"Mora","year":"2012","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1k","DOI":"10.1016\/s0002-9149(08)01833-x","article-title":"The residual risk reduction initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia","volume":"102","author":"Fruchart","year":"2008","journal-title":"Am J Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1373\/clinchem.2015.253757","article-title":"Increased remnant cholesterol explains part of residual risk of all-cause mortality in 5414 patients with ischemic heart disease","volume":"62","author":"Jepsen","year":"2016","journal-title":"Clin Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22384","article-title":"Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population","volume":"69","author":"Varbo","year":"2011","journal-title":"Ann Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","volume":"34","author":"J\u00f8rgensen","year":"2013","journal-title":"Eur Heart J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/mol.0000000000000429","article-title":"Remnant lipoproteins","volume":"28","author":"Varbo","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.835154","article-title":"Adipose tissue insulin resistance is positively associated with serum uric acid levels and hyperuricemia in northern Chinese adults","volume":"13","author":"Sun","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2019.1620206","article-title":"An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients","volume":"23","author":"Bermudez-Lopez","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11909\/j.issn.1671-5411.2018.01.011","article-title":"2016 Chinese guidelines for the management of dyslipidemia in adults","volume":"15","year":"2018","journal-title":"J Geriatr Cardiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0610","article-title":"Longitudinal change in fasting blood glucose and myocardial infarction risk in a population without diabetes","volume":"40","author":"Jin","year":"2017","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1046\/j.1440-6047.11.s8.9.x","article-title":"Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2013study on optimal cut-off points of body mass index and waist circumference in Chinese adults","volume":"15","author":"Zhou","year":"2002","journal-title":"BioMed Environ Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/01.Cir.0000125278.58527.F3","article-title":"Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype","volume":"109","author":"Twickler","year":"2004","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00184","article-title":"The forgotten lipids: Triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk","volume":"40","author":"Sandesara","year":"2019","journal-title":"Endocr Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0410-0","article-title":"Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease","volume":"16","author":"Hong","year":"2017","journal-title":"Lipids Health Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.11.008","article-title":"Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment","volume":"141","author":"Varbo","year":"2014","journal-title":"Pharmacol Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jacl.2015.08.009","article-title":"Premature myocardial infarction is strongly associated with increased levels of remnant cholesterol","volume":"9","author":"Goliasch","year":"2015","journal-title":"J Clin Lipidol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Casta\u00f1er","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13076","article-title":"A study on the correlation between remnant cholesterol and urinary albumin to creatinine ratio in Chinese community adults: A report from the REACTION study","volume":"12","author":"Li","year":"2020","journal-title":"J Diabetes"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2174\/138945009787846434","article-title":"Nonfasting hyperlipidemia and cardiovascular disease","volume":"10","author":"Nordestgaard","year":"2009","journal-title":"Curr Drug Targets"},{"key":"B37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Crosby","year":"2014","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.86.7.768","article-title":"Direct visualization of lipid deposition and reverse lipid transport in a perfused artery : roles of VLDL and HDL","volume":"86","author":"Rutledge","year":"2000","journal-title":"Circ Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.10.3.477","article-title":"Different efflux pathways for high and low density lipoproteins from porcine aortic intima","volume":"10","author":"Nordestgaard","year":"1990","journal-title":"Arteriosclerosis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00375.2015","article-title":"Systemic and renal lipids in kidney disease development and progression","volume":"310","author":"Wahl","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12933-020-01076-7","article-title":"The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes","volume":"19","author":"Cao","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202008_22499","article-title":"Inverse association between serum endocan levels and small LDL and HDL particles in patients with type 2 diabetes mellitus","volume":"24","author":"Klisic","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.951635\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T02:08:47Z","timestamp":1661393327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.951635\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":42,"alternative-id":["10.3389\/fendo.2022.951635"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.951635","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"article-number":"951635"}}